The effect of achillea millefolium on HbA1C and peripheral neuropathy in diabetic patients

Phase 2

• Conditions: Diabetes.; Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified; E08.40

• Registration Number: IRCT20150713023190N13
• Lead Sponsor: Rafsanjan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 May 2022

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

Having type II diabetes
Age over 40 years old
Inform consent for participate in the study
Getting a score above 7 from the Michigan neuropathy questionnaire
History of diabetes for at least five years

Exclusion Criteria

Participate in another research project
Having other physical illnesses in addition to diabetes
Having psychiatric diseases
Pregnancy
Lactation
History of hereditary neuropathies or underlying diseases that cause neuropathy such as chronic uremia
Autoimmune diseases (rheumatism, multiple sclerosis, osteoarthritis)
Allergy to medicinal plants
Wounds or infections on the feet
Lower extremity amputation
Use of anticoagulant drugs

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mean of HBA1C. Timepoint: At the beginning of the study (before the intervention) and 12 weeks after the intervention. Method of measurement: Spectrophotometer device.;Peripheral neuropathy score. Timepoint: At the beginning of the study (before the intervention) and 12 weeks after the intervention. Method of measurement: Michigan neuropathy questionnaire.